Antibacterial metal oxide nanoparticles: Challenges in interpreting the literature

Current Pharmaceutical Design

Volumn 24, Issue 8, 2018, Pages 896-903

  Kadiyala, Usha ^a,b,d   Kotov, Nicholas A ^a,b,c   Van Epps, J Scott ^a,b,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c University of Michigan   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Antibiotic resistance; Assembly agglomeration; Bacteria; Dose response; Metal oxides; Nanoparticles

Indexed keywords

METAL NANOPARTICLE; METAL OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; OXIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL CELL; BACTERIAL STRAIN; CONCENTRATION (PARAMETERS); DOSE RESPONSE; DRUG FORMULATION; DRUG MECHANISM; DRUG POTENCY; DRUG SYNTHESIS; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; CHEMISTRY; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN;

ANTI-BACTERIAL AGENTS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; METAL NANOPARTICLES; OXIDES;

EID: 85048869999     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612824666180219130659     Document Type: Review

References (69)

1. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. PT 2015; 40(4): 277-83.
2. Bozon-Verduraz F, Fievet F, Piquemal JY, et al. Nanoparticles of metal and metal oxides: some peculiar synthesis methods, size and shape control, application to catalysts preparation. Braz J Phys 2009; 39.
3. Jiang W, Mashayekhi H, Xing B. Bacterial toxicity comparison between nano-and micro-scaled oxide particles. Environ Pollut 2009; 157(5): 1619-25.
4. Djurišić AB, Leung YH, Ng AM, et al. Toxicity of metal oxide nanoparticles: mechanisms, characterization, and avoiding experimental artefacts. Small 2015; 11(1): 26-44.
5. Dizaj SM, Lotfipour F, Barzegar-Jalali M, Zarrintan MH, Adibkia K. Antimicrobial activity of the metals and metal oxide nanoparticles. Mater Sci Eng C 2014; 44: 278-84.
6. Horie M, Fujita K, Kato H, et al. Association of the physical and chemical properties and the cytotoxicity of metal oxide nanoparticles: metal ion release, adsorption ability and specific surface area. Metallomics: integrated biometal science 2012; 4(4): 350-60.
7. Deravi LF, Swartz JD, Wright DW. The biomimetic synthesis of metal oxide nanomaterials. Wiley; 2010.
8. Corr SA. Metal oxide nanoparticles. Nanoscience: Volume 1: Nanostructures through Chemistry. 1: The Royal Society of Chemistry; 2013. p. 180-207.
9. Allahverdiyev AM, Kon KV, Abamor ES, Bagirova M, Rafailovich M. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Expert Rev Anti Infect Ther 2011; 9(11): 1035-52.
10. Stankic S, Suman S, Haque F, Vidic J. Pure and multi metal oxide nanoparticles: synthesis, antibacterial and cytotoxic properties. J Nanobiotechnology 2016; 14(1): 73.
11. Liong M, Lu J, Kovochich M, et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008; 2(5): 889-96.
12. Microbiology: Nanoparticles kill resistant bacteria. Nature 2016; 537(7620): 282-3.
13. Miller RJ, Lenihan HS, Muller EB, Tseng N, Hanna SK, Keller AA. Impacts of metal oxide nanoparticles on marine phytoplankton. Environ Sci Technol 2010; 44(19): 7329-34.
14. Yang Y, Zhang C, Hu Z. Impact of metallic and metal oxide nanoparticles on wastewater treatment and anaerobic digestion. Environ Sci Process Impacts 2013; 15(1): 39-48.
15. Freyre-Fonseca V, Delgado-Buenrostro NL, Chirino YI, Gutiérrez-López GF. Safety Studies of Metal Oxide Nanoparticles Used in Food Industry. In: Hernández-Sánchez H, Gutiérrez-López GF, editors. Food nanoscience and nanotechnology. Cham: Springer International Publishing; 2015. p. 243-65.
16. Martirosyan A, Schneider Y-J. Engineered nanomaterials in food: implications for food safety and consumer health. Int J Environ Res Public Health 2014; 11(6): 5720-50.
17. Kong B, Seog JH, Graham LM, Lee SB. Experimental considerations on the cytotoxicity of nanoparticles. Nanomedicine (Lond) 2011; 6(5): 929-41.
18. Sekhon BS. Nanotechnology in agri-food production: An overview. Nanotechnol Sci Appl 2014; 7: 31-53.
19. Cha S-H, Hong J, McGuffie M, Yeom B, VanEpps JS, Kotov NA. Shape-dependent biomimetic inhibition of enzyme by nanoparticles and their antibacterial activity. ACS Nano 2015; 9(9): 9097-105.
20. Kotov NA. Chemistry. Inorganic nanoparticles as protein mimics. Science 2010; 330(6001): 188-9.
21. Hans M, Erbe A, Mathews S, Chen Y, Solioz M, Mücklich F. Role of copper oxides in contact killing of bacteria. Langmuir 2013; 29(52): 16160-6.
22. Bao H, Yu X, Xu C, et al. New toxicity mechanism of silver nanoparticles: promoting apoptosis and inhibiting proliferation. PLoS One 2015; 10(3): e0122535.
23. Jung WK, Koo HC, Kim KW, Shin S, Kim SH, Park YH. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol 2008; 74(7): 2171-8.
24. Xiu ZM, Zhang QB, Puppala HL, Colvin VL, Alvarez PJ. Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett 2012; 12(8): 4271-5.
25. Raghupathi KR, Koodali RT, Manna AC. Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc oxide nanoparticles. Langmuir 2011; 27(7): 4020-8.
26. Prabhu S, Poulose EK. Silver nanoparticles: Mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects. Int Nano Lett 2012; 2(1): 32.
27. Chatterjee AK, Chakraborty R, Basu T. Mechanism of antibacterial activity of copper nanoparticles. Nanotechnology 2014; 25(13): 135101.
28. Amna T, Hassan MS, Barakat NA, et al. Antibacterial activity and interaction mechanism of electrospun zinc-doped titania nanofibers. Appl Microbiol Biotecech. 2012;93.
29. Dutta RK, Nenavathu BP, Gangishetty MK, Reddy AV. Studies on antibacterial activity of ZnO nanoparticles by ROS induced lipid peroxidation. Colloids Surf B Biointerfaces 2012; 94: 143-50.
30. Yang M, Sun K, Kotov NA. Formation and assembly-disassembly processes of ZnO hexagonal pyramids driven by dipolar and excluded volume interactions. J Am Chem Soc 2010; 132(6): 1860-72.
31. Zhang H, Ji Z, Xia T, et al. Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano 2012; 6(5): 4349-68.
32. He W, Kim HK, Wamer WG, Melka D, Callahan JH, Yin JJ. Photogenerated charge carriers and reactive oxygen species in ZnO/Au hybrid nanostructures with enhanced photocatalytic and antibacterial activity. J Am Chem Soc 2014; 136(2): 750-7.
33. Li X, Xu H, Chen Z-S, Chen G. Biosynthesis of nanoparticles by microorganisms and their applications. J Nanomater 2011; 2011
34. Raliya R, Tarafdar J. Biosynthesis and characterization of zinc, magnesium and titanium nanoparticles: An eco-friendly approach. Int Nano Lett 2014; 4
35. Das VL, Thomas R, Varghese RT, Soniya EV, Mathew J, Radhakrishnan EK. Extracellular synthesis of silver nanoparticles by the Bacillus strain CS 11 isolated from industrialized area. 3 Biotech 2014; 4(2): 121-6.
36. Moore TL, Rodriguez-Lorenzo L, Hirsch V, et al. Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. Chem Soc Rev 2015; 44(17): 6287-305.
37. Fröhlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed 2012; 7: 5577-91.
38. Halder S, Yadav KK, Sarkar R, et al. Alteration of zeta potential and membrane permeability in bacteria: A study with cationic agents. Springerplus 2015; 4: 672.
39. Schaaff TG, Whetten RL. Giant gold−glutathione cluster compounds: intense optical activity in metal-based transitions. J Phys Chem B 2000; 104(12): 2630-41.
40. Noguez C, Garzón IL. Optically active metal nanoparticles. Chem Soc Rev 2009; 38(3): 757-71.
41. Gautier C, Bürgi T. Chiral gold nanoparticles. ChemPhysChem 2009; 10(3): 483-92.
42. Zhou Y, Yang M, Sun K, Tang Z, Kotov NA. Similar topological origin of chiral centers in organic and nanoscale inorganic structures: effect of stabilizer chirality on optical isomerism and growth of CdTe nanocrystals. J Am Chem Soc 2010; 132(17): 6006-13.
43. Chen W, Bian A, Agarwal A, et al. Nanoparticle superstructures made by polymerase chain reaction: collective interactions of nanoparticles and a new principle for chiral materials. Nano Lett 2009; 9(5): 2153-9.
44. Suzuki N, Wang Y, Elvati P, et al. Chiral graphene quantum dots. ACS Nano 2016; 10(2): 1744-55.
45. Vilanova O, Mittag JJ, Kelly PM, et al. Understanding the Kinetics of Protein-Nanoparticle Corona Formation. ACS Nano 2016; 10(12): 10842-50.
46. Dell’Orco D, Lundqvist M, Oslakovic C, Cedervall T, Linse S. Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS One 2010; 5(6): e10949.
47. Epa VC, Burden FR, Tassa C, Weissleder R, Shaw S, Winkler DA. Modeling biological activities of nanoparticles. Nano Lett 2012; 12(11): 5808-12.
48. Fourches D, Pu D, Tassa C, et al. Quantitative nanostructureactivity relationship modeling. ACS Nano 2010; 4(10): 5703-12.
49. Liu JL, Luo Z, Bashir S. A progressive approach on inactivation of bacteria using silver-titania nanoparticles. Biomater Sci 2013; 1(2): 194-201.
50. Stewart EJ. Growing unculturable bacteria. J Bacteriol 2012; 194(16): 4151-60.
51. Zhang Y. Persisters, persistent infections and the Yin-Yang model. Emerg Microbes Infect 2014; 3(1): e3.
52. Cai Y, Strømme M, Welch K. Bacteria viability assessment after photocatalytic treatment. 3 Biotech 2014; 4(2): 149-57.
53. Gopinath V, Priyadarshini S, Loke MF, Arunkumar J, Marsili E. Biogenic synthesis, characterization of antibacterial silver nanoparticles and its cell cytotoxicity. Arabian Journal of Chemistry
54. Boda SK, Broda J, Schiefer F, et al. Cytotoxicity of ultrasmall gold nanoparticles on planktonic and biofilm encapsulated gram-positive staphylococci. Small 2015; 11(26): 3183-93.
55. Infectious D. Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin Microbiol Infect 2003; 9(8): 9-15.
56. Xia Y, Nguyen TD, Yang M, et al. Self-assembly of self-limiting monodisperse suraparticles from polydisperse nanoparticles. Nat Nanotechnol 2011; 6(9): 580-7.
57. Allen AJ, Hackley VA, Jemian PR, Ilavsky J, Raitano JM, Chan SW. In situ ultra-small-angle X-ray scattering study of the solutionmediated formation and growth of nanocrystalline ceria. J Appl Cryst 2008; 41(5): 918-29.
58. Park JI, Nguyen TD, de Queirós Silveira G, et al. Terminal suraparticle assemblies from similarly charged protein molecules and nanoparticles. Nat Commun 2014; 5: 3593.
59. Leung YH, Xu X, Ma AP, et al. Toxicity of ZnO and TiO2 to Escherichia coli cells. Sci Rep 2016; 6: 35243.
60. 2 nanoparticles. ACS Appl Mater Interfaces 2015; 7(49): 27197-205.
61. Rosales-Colunga LM, Martínez-Antonio A. Engineering Escherichia coli K12 MG1655 to use starch. Microb Cell Fact 2014; 13: 74.
62. Kendall M, Hodges NJ, Whitwell H, Tyrrell J, Cangul H. Nanoparticle growth and surface chemistry changes in cell-conditioned culture medium. Philos Trans R Soc Lond B Biol Sci 1661; 2015: 370.
63. Cedervall T, Lynch I, Lindman S, et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 2007; 104(7): 2050-5.
64. Pino Pd, Pelaz B, Zhang Q, Maffre P, Nienhaus GU, Parak WJ. Protein corona formation around nanoparticles-from the past to the future. Mater Horiz 2014; 1(3): 301-13.
65. McGuffie MJ, Hong J, Bahng JH, et al. Zinc oxide nanoparticle suspensions and layer-by-layer coatings inhibit staphylococcal growth. Nanomedicine (Lond) 2016; 12(1): 33-42.
66. Yang M, Chan H, Zhao G, et al. Self-assembly of nanoparticles into biomimetic capsid-like nanoshells. Nat Chem 2017; 9(3): 287-94.
67. Hackley VA, Clogston JD. Measuring the hydrodynamic size of nanoparticles in aqueous media using batch-mode dynamic light scattering. In: McNeil SE, editor. Characterization of nanoparticles intended for drug delivery. Totowa, NJ: Humana Press; 2011. p. 35-52.
68. Gordon T, Perlstein B, Houbara O, Felner I, Banin E, Margel S. Synthesis and characterization of zinc/iron oxide composite nanoparticles and their antibacterial properties. Colloid Surf A. 2011;374.
69. Vidic J, Stankic S, Haque F, et al. Selective antibacterial effects of mixed ZnMgO nanoparticles. J Nanopart Res 2013; 15(5): 1595.